A

Atrys Health SA
MAD:ATRY

Watchlist Manager
Atrys Health SA
MAD:ATRY
Watchlist
Price: 2.87 EUR -3.04%
Market Cap: €218.1m

Cash Flow Statement

Cash Flow Statement
Atrys Health SA

Rotate your device to view
Cash Flow Statement
Currency: EUR
Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025
Operating Cash Flow
Net Income
0
0
0
(1)
(1)
(4)
(25)
(26)
(25)
(37)
(34)
(35)
(33)
(25)
Depreciation & Amortization
1
2
2
2
4
10
21
26
30
36
33
30
29
38
Other Non-Cash Items
0
0
1
2
98
100
19
14
7
24
34
32
34
32
Cash Taxes Paid
0
0
0
(0)
0
(0)
1
3
2
1
2
3
(1)
(1)
Cash Interest Paid
1
1
1
1
2
5
10
13
15
19
25
26
21
19
Change in Working Capital
(3)
(2)
(2)
(2)
(101)
(99)
(10)
(29)
(29)
(33)
(28)
(33)
(27)
(12)
Cash from Operating Activities
(1)
N/A
0
N/A
1
+1 123%
2
+43%
(1)
N/A
6
N/A
5
-23%
(15)
N/A
(15)
-3%
(10)
+35%
6
N/A
(6)
N/A
3
N/A
23
+677%
Investing Cash Flow
Capital Expenditures
(2)
(3)
(5)
(7)
(5)
(9)
(9)
(5)
(15)
(18)
(13)
(12)
(13)
(13)
Other Items
(5)
(11)
(16)
(10)
(47)
(57)
6
(55)
(65)
9
14
2
0
8
Cash from Investing Activities
(8)
N/A
(14)
-88%
(21)
-47%
(17)
+19%
(52)
-203%
(67)
-28%
(2)
+96%
(60)
-2 331%
(81)
-35%
(8)
+90%
0
N/A
(10)
N/A
(13)
-33%
(5)
+59%
Financing Cash Flow
Net Issuance of Common Stock
4
0
5
5
34
34
(0)
72
82
10
0
1
(0)
(0)
Net Issuance of Debt
5
5
13
17
28
36
14
19
12
(8)
1
6
(11)
(16)
Cash from Financing Activities
9
N/A
6
-38%
19
+233%
22
+21%
63
+179%
70
+12%
14
-80%
91
+548%
95
+4%
3
-97%
1
-47%
6
+355%
(12)
N/A
(16)
-37%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
1
1
0
(0)
0
1
0
(1)
Net Change in Cash
0
N/A
(9)
N/A
(1)
+84%
7
N/A
9
+33%
10
+8%
18
+78%
18
-1%
(1)
N/A
(16)
-1 796%
8
N/A
(8)
N/A
(21)
-177%
2
N/A
Free Cash Flow
Free Cash Flow
(3)
N/A
(3)
-2%
(4)
-14%
(5)
-40%
(7)
-28%
(3)
+50%
(4)
-16%
(19)
-403%
(31)
-57%
(28)
+9%
(7)
+73%
(18)
-143%
(10)
+44%
10
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett